- Intel's recent run now faces a challenge at $27.42
- Upper Bollinger Band® currently at $32.11
Technical analysis trend indicators suggest that around $26.49, Intel can look to establish a new bullish phase beyond its 21 day Simple Moving Average. Asset volatility analysis shows that Intel's upper Bollinger Band® is now at $27.91. A study of Intel's historical price actions shows Intel's recent run now faces a major challenge as concentrated supply is likely found at $27.42 with price action currently 45 cents away.
Notwithstanding Intel's appreciation in recent days, the technical outlook suggests its bullish run is now fading.
Technical analysis shows that Chemed Corp. is trending down and heading towards $436.72, which is only $6.19 away now. Hitting this support line might signal a change of direction. With regards to technical trend indicators, chart analysis show that $444.71 marks the crossover point where Chemed Corp. price action falls below its 21 day Simple Moving Average. According to asset volatility analysis, Chemed Corp.'s lower Bollinger Band® is at $431.33.
For the time being, Chemed Corp. remains flat without a clear direction.
Around $31.67, GlaxoSmithKline can look to establish a new bullish phase beyond its 50 day Simple Moving Average. Price action overcame a known Fibonacci resistance level at $31.47 by around 40 cents with prices hammering out a $31.1 – $32.02 session range. In contrast, Glaxo's run now faces a challenge at $32.23, which is only 36 cents away from the line. Overcoming it might send the company towards their next major resistance line— this will surely be interesting to follow. GlaxoSmithKline's upper Bollinger Band® is at $32.11.
According to technical analysis, it looks as if GlaxoSmithKline likely to continue pointing upward in the short term.
Upcoming fundamentals: projections for United States Consumer Confidence are set for a continuation of decline with 106.5 while previous data was 108; data will be released tomorrow at 14:00 UTC.